Viemed Healthcare Inc(VMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:30 PM ET (Korea 9/12 08:30)
Full metrics table
| Index | RUT | P/E | 24.02 | EPS (ttm) | 0.37 | Insider Own | 13.84% | Shs Outstand | 38.1M | Perf Week | -2.44% |
| Market Cap | 0.33B | Forward P/E | 16.18 | EPS next Y | 31.45% | Insider Trans | -3.07% | Shs Float | 32.8M | Perf Month | -5.08% |
| Enterprise Value | 0.34B | PEG | 0.7 | EPS next Q | 0.12 | Inst Own | 74.74% | Short Float | 3.68% | Perf Quarter | -15.64% |
| Income | 0.01B | P/S | 1.11 | EPS this Y | 11.71% | Inst Trans | 4.54% | Short Ratio | 3.15 | Perf Half Y | -3.19% |
| Sales | 0.30B | P/B | 2.32 | EPS next 5Y | 23.09% | ROA | 7.46% | Short Interest | 1.21M | Perf YTD | 18.3% |
| Book/sh | 3.78 | P/C | 31.35 | EPS past 3/5Y | 32.77% -14.01% | ROE | 10.22% | 52W High | -30.29% ($12.61) | Perf Year | 27.02% |
| Cash/sh | 0.28 | P/FCF | 11.45 | Sales past 3/5Y | 24.87% 15.53% | ROIC | 9.45% | 52W Low | 45.29% ($6.05) | Perf 3Y | 16.58% |
| Dividend Est. | - | EV/EBITDA | 6.05 | EPS Y/Y TTM | 6.14% | Gross Margin | 56.95% | Volatility(W/M) | 2.24% 2.97% | Perf 5Y | 41.32% |
| Dividend TTM | - | EV/Sales | 1.12 | Sales Y/Y TTM | 25.21% | Oper. Margin | 8.47% | ATR (14) | 0.3 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.02 | EPS Q/Q | -12.5% | Profit Margin | 4.81% | RSI (14) | 36.13 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.13 | Sales Q/Q | 23.85% | SMA20 | -1.72% ($8.94) | Beta | 1.05 | Target Price | $12.5 |
| Payout | - | Debt/Eq | 0.08 | Earnings | 2026/8/3 | SMA50 | -15.19% ($10.36) | Rel Volume | 0.53 | Prev Close | $8.75 |
| Employees | 1382 | LT Debt/Eq | 0.07 | EPS/Sales Surpr. | -41.67% 0.13% | SMA200 | -4.31% ($9.19) | Avg Volume(3M) | 0.38M | Price | $8.79 |
| IPO | 2018/1/4 | Option/Short | Yes/Yes | Trades | 3687 | Volume | 201,815 | Change | 0.46% |
Company
VMD is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
Vimed Healthcare (VMD) is a U.S.-based medical device and home healthcare company that provides home non-invasive ventilation therapy and related medical device and consumable resupply services for patients with chronic respiratory diseases. Going beyond simple device sales, it operates an integrated care model in which clinical staff directly manage patients, and has established a position in a niche market on the back of high patient retention and strong insurance reimbursement approval capabilities.
Over the past 1 year, roughly in the middle
30% below its 1-year high.
VMD makes money exceptionally well
8.47% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +11.7% this year.
Tap to view numbers
The price looks about right
Trading at 24.0 times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +16.6% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 74.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
FDM 0.00%
ROSC 0.00%
SYZ 0.00%
SMLV 0.00%
IWC 0.00%It ranks #4 in the industry
Based on market cap of $335M.
VMD $335M PER 24.0
ABT $176B PER 33.0
MDT $116B PER 22.4
SYK $106B PER 28.6
FAQ
What kind of company is VMD?
VMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of VMD?
The market cap of VMD is approximately $335M, ranking 3,599 within its sector.
What is the P/E ratio of VMD?
VMD has a P/E ratio of approximately 24.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for VMD?
VMD has recorded a 52-week high of $12.61 and a low of $6.05.
